ZipLine Medical, a Campbell, Calif.-based medical device company, closed a $5.7m extension to its Series C financing, which was announced on Jan. 21, 2014 (read here).
The round was led by new investor China Materialia LLC, with participation from existing investors RA Capital Management (Boston, MA), Claremont Creek Ventures (Oakland, CA) and XSeed Capital (Portola Valley, Calif.). In conjunction with the funding, Min Zhou, PhD, co-founder and CEO of China Materialia, has joined ZipLine’s board of directors.
The company intends to use the funds to expand sales and marketing activities.
Founded by Amir Belson, MD, and led by John Tighe, President and CEO, ZipLine Medical is a medical device company that is developing noninvasive surgical skin closure devices for suture-like outcomes at the speed of staples, with a reduced risk of surgical site infection.
Zip® Surgical Skin Closure devices are classified by the U.S. FDA as ‘Class I, 510(k) Exempt’ and have received CE Mark.
FinSMEs
20/10/2014